Relationships of Serum Iron Parameters and Hemoglobin with Forced Expiratory Volume in 1 Second in Patients with Chronic Obstructive Pulmonary Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Although chronic obstructive pulmonary disease is a known cause of secondary polycythemia with elevated erythropoietic demands in response to hypoxemia, anemia is relatively common in patients with chronic obstructive pulmonary disease and is related to increased mortality. However, little is currently known about the relationship between various iron parameters and disease severity in chronic obstructive pulmonary disease pa-tients.Methods: Data from the fifth Korean National Health and Nutrition Examination Survey, a population-based epi-demiologic survey conducted in 2010–2012, were used. A total of 1,129 patients with chronic obstructive pulmo-nary disease were examined to reveal the associations between the forced expiratory volume in 1 second (FEV1) and hemoglobin and iron parameters, including serum iron, ferritin, total iron binding capacity, and transferrin saturation, using Spearman correlations and multiple linear regression analyses.Results: The FEV1 was positively correlated with serum hemoglobin (g=0.37, P<0.001), iron (g=0.20, P<0.001), transferrin saturation (g=0.19, P<0.001), and ferritin (g=0.22, P<0.001), and negatively correlated with age (g=-0.40, P<0.001) and lower in female patients (g=-0.56, P<0.001) in the Spearman correlation. The FEV1 was independently associated with serum iron (b=0.049, P=0.035) and transferrin saturation (b=0.049, P=0.035) after adjusting for age, sex, and body mass index in the multiple linear regression analyses.Conclusion: The serum iron and transferrin saturation levels were independently associated with FEV1 as a marker of chronic obstructive pulmonary disease severity.
Abstract
Background: Although chronic obstructive pulmonary disease is a known cause of secondary polycythemia with elevated erythropoietic demands in response to hypoxemia, anemia is relatively common in patients with chronic obstructive pulmonary disease and is related to increased mortality. However, little is currently known about the relationship between various iron parameters and disease severity in chronic obstructive pulmonary disease pa-tients.Methods: Data from the fifth Korean National Health and Nutrition Examination Survey, a population-based epi-demiologic survey conducted in 2010–2012, were used. A total of 1,129 patients with chronic obstructive pulmo-nary disease were examined to reveal the associations between the forced expiratory volume in 1 second (FEV1) and hemoglobin and iron parameters, including serum iron, ferritin, total iron binding capacity, and transferrin saturation, using Spearman correlations and multiple linear regression analyses.Results: The FEV1 was positively correlated with serum hemoglobin (g=0.37, P<0.001), iron (g=0.20, P<0.001), transferrin saturation (g=0.19, P<0.001), and ferritin (g=0.22, P<0.001), and negatively correlated with age (g=-0.40, P<0.001) and lower in female patients (g=-0.56, P<0.001) in the Spearman correlation. The FEV1 was independently associated with serum iron (b=0.049, P=0.035) and transferrin saturation (b=0.049, P=0.035) after adjusting for age, sex, and body mass index in the multiple linear regression analyses.Conclusion: The serum iron and transferrin saturation levels were independently associated with FEV1 as a marker of chronic obstructive pulmonary disease severity.
참고문헌 (20)
- Pauwels RA, "NHLBI", WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary, 2001, pp.163, 1256~1276
- Kent BD, "Hypoxemia in patients with COPD: cause, effects, and disease progression", Int J Chron Obstruct Pulmon Dis, 6, pp.199~208 (2011)
- Armitage AE, "Hepcidin regulation by innate immune and infectious stimuli", Blood, 118, pp.4129~4139 (2011)[DOI]
- Similowski T, "The potential impact of anaemia of chronic disease in COPD", Eur Respir J, 27, pp.390~396 (2006)[DOI]
- Rogers J, "The role of cytokines in the regulation of ferritin expression", Adv Exp Med Biol, 356, pp.127~132 (1994)
- Means RT Jr, "Advances in the anemia of chronic disease", Int J Hematol, 70, pp.7~12 (1999)
- Markoulaki D, "Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease", Eur J Intern Med, 22, pp.103~107 (2011)[DOI]
- Rabe KF, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary", Am J Respir Crit Care Med, 176, pp.532~555 (2007)[DOI]
- Checkley W, "Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease", Respir Med, 111, pp.30~38 (2016)[DOI]
- Miller MR, "New concepts for expressing forced expiratory volume in 1 s arising from survival analysis", Eur Respir J, 35, pp.873~882 (2010)[DOI]
- Schneckenpointner R, "The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure", Int J Clin Pract, 68, pp.130~138 (2014)[DOI]
- Hirayama F, "Dietary intake of six minerals in relation to the risk of chronic obstructive pulmonary disease", Asia Pac J Clin Nutr, 19, pp.572~577 (2010)
- Cavill I, "Iron status as measured by serum ferritin: the marker and its limitations", Am J Kidney Dis, 34(4 Suppl 2), pp.S12~S17 (1999)[DOI]
- Barberan-Garcia A, "Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD", Respirology, 20, pp.1089~1095 (2015)[DOI]
- Locatelli F, "Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement", Nephrol Dial Transplant, 28, pp.1346~1359 (2013)[DOI]
- Anker SD, "Ferric carboxymaltose in patients with heart failure and iron deficiency", N Engl J Med, 361, pp.2436~2448 (2009)[DOI]
- Okonko DO, "Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial", J Am Coll Cardiol, 51, pp.103~112 (2008)[DOI]
- Silverberg DS, "Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron", BMC Pulm Med, 14, pp.24~ (2014)[DOI]
- Nand S, "Pulmonary hypertension in polycythemia vera", Am J Hematol, 47, pp.242~244 (1994)[DOI]
- American Thoracic Society, "Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 152(5), pp.S77~S121 (1995)
